Institute for Personalized Medicine to become a platform for innovation testing

Institute for Personalized Medicine, based in Science & Technology Park for Biomedicine of Sechenov University (Moscow, Russia), has successfully completed a pilot testing of a device for double-dose drip-infusion “SN-1500H Infusion Pump” under the framework of the “Open requests” international program.  

The program allows high-tech companies to introduce and to test innovative products that are necessary for Moscow citizens within urban environment.

The device is designed for infusion of drugs into a patient’s body by achieving uniform dose and accurately controlled speed. The test results have confirmed effectiveness of the device, and it’s recommended for widespread use in Moscow.

The main goal of the Institute for Personalized Medicine is development and implementation in clinical practice of new approaches in diagnosis, treatment, prevention and rehabilitation in accordance with all modern research achievements.

SOURCE: sechenov.ru
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.